The U.S. Food and Drug Administration for the first time approved a vaccine that protects against the deadly Ebola virus.
The vaccine, Ervebo, is for the prevention of Ebola virus disease caused by Zaire ebolavirus in people 18 and older, the agency said Thursday.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.